Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.
about
New insights into the burden and costs of multiple sclerosis in Europe.Cost of Illness of Multiple Sclerosis - A Systematic Review.Cost-effectiveness analyses in multiple sclerosis: a review of modelling approaches.Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies.A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis.Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
P2860
Q33811618-B8C95ECA-1AFD-4154-8CBC-7F237356F392Q36076087-768D4528-92F4-4206-B12C-2D94BE19167FQ38197076-8FB325BB-7D17-4EED-8C69-8CE8B235D3BAQ38570681-D868C77C-159D-4F89-B6AF-624672E59D83Q47793816-EADAAFE9-C4E8-4E19-AF92-AB888EE83590Q50111623-B0859F56-489C-48EF-90C3-1348BF659871Q50976326-1CCEAE78-7A38-4D56-90F0-2C4650307705
P2860
Modelling the cost effectiveness of disease-modifying treatments for multiple sclerosis: issues to consider.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Modelling the cost effectivene ...... sclerosis: issues to consider.
@en
type
label
Modelling the cost effectivene ...... sclerosis: issues to consider.
@en
prefLabel
Modelling the cost effectivene ...... sclerosis: issues to consider.
@en
P2860
P1433
P1476
Modelling the cost effectivene ...... sclerosis: issues to consider
@en
P2093
Joel P Thompson
Katia Noyes
P2860
P2888
P304
P356
10.1007/S40273-013-0063-4
P577
2013-06-01T00:00:00Z